PT  - JOURNAL ARTICLE
AU  - Davlyathon Maksumov
AU  - Rustem Hayaliev
AU  - Bahrom Amanov
TI  - Surgical treatment of relapsed hydatid disease of lungs
DP  - 2014 Sep 01
TA  - European Respiratory Journal
PG  - P2430
VI  - 44
IP  - Suppl 58
4099  - http://erj.ersjournals.com/content/44/Suppl_58/P2430.short
4100  - http://erj.ersjournals.com/content/44/Suppl_58/P2430.full
SO  - Eur Respir J2014 Sep 01; 44
AB  - Hydatid disease - a serious parasitic disease of humans, which is often found in countries with livestock and is endemic to the Central Asian republics, including Uzbekistan. The surgical treatment of hydatid disease of lungs is unique and the most radical, however and after operations the development of relapses is possible. On the data of the literature the relapse of hydatid disease after surgical treatment does not tend to decrease and changes from 4% up to 48%.We have an experience of treatment 2945 patients with hydatid disease of lungs. From 2945 operated patients concerning the various forms of hydatid disease of lungs relapse of disease from 1 to 7 years we observed in 184 (6,24%) patients. From them: men - 103 (55,9%), women - 81 (44,1%). The age of the patients varied from 9 to 74 years. From 184 patients 152 (82,6%) undergone operations, not operated 32 (17,39%) - the reason was disseminated process, wide distribution of hydatid cysts. 142 (93,4%) patients were performed organsaving operation, 10 (6,6%) patients underwent resections.In the postoperative period albendazole was administered in a doze 10-12 mg/kg/day, quantity of courses depended on the form of a defeat. Using preventive chemotherapy realistically reduces the risk of the development of the relapse of hydatid disease, hereunder, rescuing patient from the repeated operations and possible complications. The following pictures show relapsed multiple hydatid disease of lungs.